AHZ IPO'd at ~$0.75 and at that valuation, it was:
- Without VascuCel FDA approval
- Without the positive results of the HSV2 trial (rendering AHZ's product best-in-world and probably improvable too)
The share price should be $2 right now - and probably will reach that in an instant as soon as positive revenue announcements start coming.
Look at RAP as a comparison - no revenue, no FDA approval, no one uses telehealth, etc, etc and due to managements' various announcements, the market has shot it up to a MC of $300M!!
AHZ MC is $100M.
Insane.
- Forums
- ASX - By Stock
- AVR
- Admedus - the FA thread
Admedus - the FA thread, page-13
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$15.00 |
Change
0.000(0.00%) |
Mkt cap ! $317.0M |
Open | High | Low | Value | Volume |
$15.00 | $15.00 | $14.36 | $82.01K | 5.582K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50 | $14.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.00 | 5141 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50 | 14.700 |
1 | 198 | 14.600 |
1 | 200 | 14.500 |
1 | 60 | 14.350 |
1 | 200 | 14.300 |
Price($) | Vol. | No. |
---|---|---|
15.000 | 5141 | 3 |
15.150 | 204 | 1 |
15.500 | 44 | 1 |
16.030 | 999 | 1 |
16.500 | 971 | 1 |
Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online